Lyras Pharma ApS

CVR 45525813 · Private limited company (ApS) · Active · High risk

Lyras Pharma ApS is a Private limited company (ApS), founded on , based in Aalborg. The company is registered in the industry fremstilling af andre maskiner til generelle formål i.a.n.. Our model estimates a bankruptcy risk of 6.5% over the next 12 months, which is 4.6 times the average for Danish companies. 1 annual report has been published, of which 1 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 453k and a net result of DKK 433k. CEO: Nete Zarp Nielsen.

Bankruptcy risk for Lyras Pharma ApS

6.5%
probability of bankruptcy within 12 months
High risk

4.6 × the average (1.41%) · higher risk than 94% of active Danish companies

Lowest riskHighest risk

Increases the risk

Share of late annual reports75%+ · bankruptcy rate 29.8%3.4×
Age (years)1 yrs · bankruptcy rate 21.6%2.5×
Published annual reports1 · bankruptcy rate 18.7%2.1×
CEO changes in the last year2+ · bankruptcy rate 18.5%2.1×
Time since new CEO0.5–1 yrs · bankruptcy rate 15.6%1.8×
Time at current address1 yrs · bankruptcy rate 14.0%1.6×
Annual reports filed late1 · bankruptcy rate 11.3%1.3×

Reduces the risk

Equity vs. share capital5+× · bankruptcy rate 2.5%0.28×
Auditor's statementExtended review · bankruptcy rate 2.9%0.33×
Number of auditors (historical)2 · bankruptcy rate 4.6%0.52×
Equity ratio40%–60% · bankruptcy rate 4.6%0.52×
Auditor resigned in the last yearYes · bankruptcy rate 4.6%0.52×
Auditor registered in CVRYes · bankruptcy rate 4.8%0.55×
Audit opted outNo · bankruptcy rate 4.8%0.55×
Return on assets15%+ · bankruptcy rate 5.1%0.58×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
45525813
Status
Active
Company type
Private limited company (ApS)
Founded
(1 years)
Address
Lyngvej 7
9000 Aalborg
Municipality
Aalborg
Industry
Fremstilling af andre maskiner til generelle formål i.a.n. (282900)
Bankruptcies in the industry: Fremstilling af øvrige maskiner til specielle formål i.a.n.
Share capital
DKK 20k
Auditor
Cedra Godkendt Revisionsaktieselskab
Audit opted out
No

Warning signs

Annual reports filed late1 of 1
Missing annual reportNo
Negative equityNo
Equity ratio41.4%
Current ratio171%
Moves (last 2 years)0
CEO changes in total2
CEO's previous bankruptcies0
Other companies at the address7
Going-concern uncertaintyNo

Financials and key figures

Financial year2025
Gross profitDKK 558k
Net profitDKK 433k
EquityDKK 453k
Total assetsDKK 1.1m
CashDKK 894
Short-term debtDKK 641k
Avg. employees0

Latest annual report: Reporting class B · auditor's statement: Erklæring om udvidet gennemgang · Deloitte Statsautoriseret Revisionspartnerselskab.

Filed annual reports

Reporting periodPublishedDays after period end
8 Apr 2025 – 31 Dec 2025187 Late

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEONete Zarp NielsenCurrent
CEOMark Kalhøj Andersen
BoardMads Kristoffer Storgaard MehlsenCurrent
BoardKenneth Sandfeld HansenCurrent
BoardLars Colding-KristensenCurrent
BoardJan NygaardCurrent
BoardThomas Dall EwersCurrent
BoardRasmus MortensenCurrent
Owner (100%)Lyras DK ApSCurrent
AuditorCedra Godkendt RevisionsaktieselskabCurrent
AuditorDELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB
FounderLyras DK ApSCurrent

The CEOs' other companies

Nete Zarp Nielsen – 3 other companies, of which 1 bankrupt

Address history (0 moves)

Lyngvej 7, 9000 Aalborg

Other companies at the same address

Similar companies in Aalborg

Questions and answers about Lyras Pharma ApS

Has Lyras Pharma ApS gone bankrupt?

No, Lyras Pharma ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of Lyras Pharma ApS?

Our model estimates a bankruptcy risk of 6.5% over the next 12 months (high risk), which is 4.6 times the average for Danish companies.

Who is the CEO of Lyras Pharma ApS?

Nete Zarp Nielsen is the CEO of Lyras Pharma ApS.

Who is the auditor of Lyras Pharma ApS?

Lyras Pharma ApS most recently used Cedra Godkendt Revisionsaktieselskab.

When was Lyras Pharma ApS founded?

Lyras Pharma ApS was founded on 8 April 2025.

What is the equity of Lyras Pharma ApS?

Equity was DKK 453k according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.